CCP VirusVaccines & Safety

China’s Sinovac Vaccine Efficacy Called Into Question, Thailand Opts for AstraZeneca Booster

Save
China’s Sinovac Vaccine Efficacy Called Into Question, Thailand Opts for AstraZeneca Booster
A woman receives a dose of Sinovac's Covid-19 coronavirus vaccine during a vaccination drive in Banda Aceh, Indonesia on July 7, 2021. Chaideer Mahyuddin/AFP via Getty Images
Lisa Bian
Updated:

Thailand is currently experiencing a spike in COVID-19 infections. On July 11, the number of cases reported reached a record high of 9,418. The death toll on July 10 was 91, also a historic high. Due to the abrupt rise in cases, the Thailand government changed its vaccine policy, and started giving the AstraZeneca (AZ) vaccine to boost protection for those who received China’s Sinovac.

On July 11, Thailand’s Ministry of Public Health said 618 of 677,348 medical staff who were fully vaccinated with Sinovac vaccine were infected with the Chinese Communist Party (CCP) Virus. One nurse died, and one medical staff was in critical condition.

Lisa Bian
Lisa Bian
Author
Lisa Bian, B.Med.Sc., is a healthcare professional holding a Bachelor's Degree in Medical Science. With a rich background, she has accrued over three years of hands-on experience as a Traditional Chinese Medicine physician. In addition to her clinical expertise, she serves as an accomplished writer based in Korea, providing valuable contributions to The Epoch Times. Her insightful pieces cover a range of topics, including integrative medicine, Korean society, culture, and international relations.
Related Topics